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Summary
Injury to the blood brain barrier (BBB) is a fundamental sequela of bacterial meningitis, yet
the precise mechanism facilitating exudation of albumin across the endothelium of the cerebral
microvasculature remains conjectural. After intracisternal inoculation ofEscherichia coli (0111:B4)
lipopolysaccharide in rats to elicit a reversible meningitis and BBB injury, we utilized in situ
tracer perfusion and immunolabeling procedures to identify by transmission electron microscopy
the precise topography and microvascular exit pathway(s) ofbovine serum albumin (BSA) . Results
revealed that during meningitis there was : (a) an inducible increase in immunodetectable monomeric
BSA binding to the luminal membrane of all microvascular segments in the pia-arachnoid and
superficial brain cortex ; (b) similar uptake ofboth colloidal Au-BSA (as well as monomeric BSA)
by plasmalemmal vesicles but no detectable transcytosis to the abluminal side; and (c) predominant
exit ofboth perfused Au-BSA and immunodetectable monomericBSA through open intercellular
junctions of venules in the pia-arachnoid. This was corroborated in separate experiments
documenting focal pial venular leaks of in situ perfused 0.01% colloidal carbon black during
experimental meningitis . These results provide precise localization ofBBB injury in meningitis
to meningeal venules, confirm a paracellular exit pathway of albumin via open intercellularjunctions,
and suggest an injury mechanism amenable to specific therapeutic intervention .
B
acterial meningitis remains a common disease with un-
acceptable morbidity and mortality despite bactericidal
antibiotic therapy. This observation supports the hypothesis
that pathophysiologic sequelae of the disease progress despite
bacteriologic cure and effect irreversible neuronal injury (1) .
The blood brain barrier (BBB)' represents one critical site
functionally injured in meningitis, with the resultant central
nervous system protein exudation a physiologic precipitant
of vasogenic brain edema. Anatomically, investigation has
localized the cerebral microvasculature as the major site respon-
sible for the BBB due to its unique ultrastructural features:
primarily rare plasmalemmal vesicles and continuous inter-
cellular tight junctions (2-4) . These unique features impart
upon it the characteristics of a high resistance endothelium
(5), allowing it to function as a barrier to macromolecular
(i .e ., albumin) transport as well as to facilitate integration
of neuronal synaptic information .
1 Abbreviations used in this paper: BBB, blood brain barrier; PV, plasmalem-
mal vesicles; RSA, endogenous rat serum albumin; TEM, transmission
electron microscopy.
In systemic microvasculature, ultrastructural mechanisms
of albumin transport have been recently investigated .
Specifically, using the method of in situ administration of
colloidal gold-albumin complexes, evidence exists that there
are specific luminal membrane binding microdomains for al-
bumin . Topographically, they appear restricted to uncoated
pits and plasmalemmal vesicles that appear to function in
receptor-mediated transcytosis (6) . Therefore, a major ques-
tion arises from a clinical and biological perspective as to the
precise mechanism facilitating albumin exudation across the
cerebral microvasculature during infectious injury. In this in-
quiry, using a rat model of meningitis, we sought to inves-
tigate three basic questions . (a) What is the topographic lo-
cation of cerebral microvascular injury during meningeal
inflammation? Is it localized to the leptomeninges, or does
it extend to the parenchymal microvasculature? (b) Which
microvascular segments (i.e., arteriolar, capillary, or venular)
are predominantly affected? (c) Is there evidence ofa primary
transcellular or paracellular pathway of albumin exit out ofthe
microvasculature during meningitis? To investigate these ques-
tions, we utilized in situ perfusion ofcolloidal gold-BSA com-
plexes as well as immunogold labeling ofperfused monomeric
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Volume 174 September 1991 657-672BSA to localize, by transmission electron microscopy (TEM),
albumin exit pathways during experimental meningitis.
Materials and Methods
Materials
HAu Cl,, BSA, OVA, poly-L-glutamic acid (mol wt, 15,000-
50,000), and biotinylated goat anti-rat IgG were purchased from
Sigma Chemical Co. (St. Louis, MO). Escherichia coli 0111:B4 LPS
was a gift from Dr.J. Ryan, Yale University. 125-1 BSA was pur-
chased from ICN Radiochemicals (Irvine, CA). M 199powder was
obtained from GibcoLaboratories, (Grand Island, NY), andFreund's
adjuvant from Difco Laboratories (Detroit, MI). Protein G was
bought from Pierce Chemical Co. (Rockford, 1L). Goat anti-rat
IgG-Au(5nm) was obtained from Janssen Life Sciences Products
(Piscataway, NJ). Ketamine wasbought from Parke Davis (Morris
Plains, NJ)* andXylazine from MilesLaboratories (Shawnee, KS).
Butterfly needles were purchased from Abbott (North Chicago,
IL), andglutaraldehyde,propyleneoxide, Epon, anduranyl acetate
were obtained from E.M. Sciences (Ft. Washington, PA).
Preparation of Colloidal Cold-BSA Tracer
Colloidal gold particles with mean diameter of 5 nm were pre-
pared by reducing HAuCL with a combination of Na citrate and
tannic acid as previously described (7). After a 72-h dialysis vs.
ddH20, the optimalligand (BSA) coupling concentration was de-
termined to be 80 jig/ml by the NaCl aggregation method. BSA
(80 NAg/ml of a previously dialyzed 1% BSA solution) was then
coupled to the colloidal gold solution, stabilized with poly-L-
glutamic acid (200 lAg/ml of a previously dialyzed 1% solution),
and ultracentrifuged (180,000 g for 45 min) with the soft pellet
resuspended in PBS-glutamic acid (200 14g/ml), and the OD520 ad-
justed to 1.0 for perfusion experiments. As a control tracer solu-
tion, colloidal gold uncoupled to protein was stabilized with the
poly-L-glutamic acid, ultracentrifuged, and diluted to OD520 = 1.0
analogous to the method for colloidal gold-BSA. Tracer solutions
were kept at 4°C, documented to be monodisperse by TEMbefore
use, and were utilized for perfusions within 2 h of preparation.
Induction of Experimental Meningitis
The technique used was previously described (8). Adult male
Wistar rats (125 gm) were anesthetized with ketamine (100
mg/kg)/xylazine (7 mg/kg) by the intramuscular route. After
removalof75 pl ofCSFby intracisternalpuncture usinga25-gauge
butterfly needle, 50 u1 of LPS solution (containing 25 ng of E.
coli 0111:B4 purified LPS) was injected intracistemally into each
experimental animal with 50 fit ofpyrogen-free saline inoculated
into controls.Afterdefined durations ofdiseasedevelopment, menin-
gitis was confirmed histologically by light microscopy, and CSF
pleocytosis was quantitated by a second cisternal puncture using
standard hemocytometry to determine the natural history of the
CSF inflammatory response in vivo.Similarly, theonset, peak, and
duration offunctional BBBinjurywasdetermined by CSF penetra-
tion of systemically administered 'uI-BSA (10 pCi) 1 hbefore the
second cisternal puncture.At the time ofthis second cisternal punc-
ture, CSF and blood sampleswere simultaneously obtained forra-
dioactive assay in a Gamma 300 counter (Beckman Instruments
Inc., Irvine, CA). As previously described, only CSF samples
without visible blood contamination were evaluated and the per-
cent CSF penetration of 'uI-BSA was determined from theequa-
tion: 100 x 1251 cpm per ml CSF/1251 cpm per ml blood.
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In Situ Perfusion Protocols during Experimental Meningitis
Colloidal Gold-BSA Experiments.
￿
At the time of peak CSF
inflammation and functional CSF transport of "I-BSA (4 h post-
LPS intracisternal inoculation), rats were anesthetized, a thora-
cotomy was done, andthevasculature was perfused in situ in four
sequential steps via theleft ventricle with the right atrium cut to
allowperfusate outflow: (a) a flush with oxygenated M199 media
supplemented with glucose and HCO3 ("supplemented M199") at
37°C, pH 7.4, using a perfusion rate of 15 ml/min for 10 min
to ensure optimalCNSperfusion; (b) perfusionwith Au-BSA (sta-
bilized with poly-L-glutamic acid) solution (ODs20 = 1.0) at the
15-ml/minflow rate for10 min; (c) repeat flush with supplemented
M199 mediaat 15 ml/min for 1 min; (d) in situ fixation with 3%
glutaraldehyde in 0.1 MNa cacodylate, pH 7.4, supplemented with
0.1 mM MgC12 and 0.1 mM CaC12 at 15 ml/nun for 10 min.
Control groups included rats inoculated intracisternally with PBS
(i.e., uninflamed controls), as well as rats inoculated with LPS
(inflamed rats) in which the perfusion step consisted of colloidal
gold stabilized by glutamic acid alone. Afterin situ fixation, cere-
bral cortex with intact piawasremoved, cutinto 5-mm cubes, placed
in 2% osmium tetroxide, stained en bloc with 2% uranyl acetate,
followed by standard embedding in Epon 812. Thin sections cut
on an ultramicrotome were then stained with uranyl acetate and
lead citrate and examined with TEM.
Carbon Black F~rfusion Experiments.
￿
To assess the topography
of the leptomeningeal injury, animals inoculated intracisternally
with LPS (and controls) were perfusion fixed in situ in one step
via the left ventricle with a0.01% carbon black (vol/vol) solution
in 3% glutaraldehyde (supplemented with 0.1 mM MgC12 and 0.1
mM CaC12 as before) at 15 ml/min for 10 min. The pial surface
was then examined at 40x usingadissecting microscope andpho-
tographed to detect areas of carbon leak.
Immunolocalization ofBSA after Experimental Meningitis
Production ofPrimary Antibody.
￿
125-gm rats were immunized
with various concentration of BSA (50-250,ug) in Freund's adju-
vant. Afterthefourth injection, serumwascollected, andratanti-
BSAIg Gwaspurified by protein Gaffinity chromatography with
confirmation by SDS-PAGE. Purified antibody was kept frozen
(-70°C) in 10-Al aliquots before use.
ELISA Determination ofOptimalFixation Conditions.
￿
To deter-
mine the optimalconcentrationofaldehyde fixation for in situ BSA
immunolocalization, ELISAs were performedusingBSAas antigen
and thepurified ratanti-BSA Ig G as primaryantibody in the face
of different fixative concentrations. From this, the sensitivity and
specificity of the primary antibody were tested in the setting of
different aldehyde fixative concentrations to determineoptimal con-
ditions for BSA immunodetection in situ.
In Situ Ikfusion with Monomeric Tracer Free BSA.
￿
At a similar
time of peak CSF inflammation (4 h post-LPS inoculation),
anesthesia and thoracotomy were performed, and the vasculature
similarly perfused in situ in sequential steps: (a) a flushwith oxy-
genated supplemented M199 at 37°C usinga 15-ml/min flow rate
for 10 min; (b) perfusion with 40 mg/ml of a monomeric BSA
(fraction V) solution for different time intervals (1 min, 10 min)
at thesame 15-ml/minflow rate; (c) in situ fixationwith4% parafor-
maldehyde/0.5%glutaraldehyde in 0.1 MNa cacodylate (pH 7.4).
Immunofluorescent BSA Localization In Situ.
￿
To determine the
ability of the primaryanti-BSA antibody to localize BSAperfused
in situ, heartandbraincortices were cut into 1-mm coronalslices,
frozen in liquid N2, and cryosectioned (5-trm thickness) on a
Frigocut (ReichertScientific Instruments, Buffalo, NY). Cryostat
Ultrastructural Localization of Albumin Exit Pathways in Meningitissections were then treated in the followingway: (a) incubated with
rat-anti-BSA (1:200 dilution in PBS, 1% OVA) for 1 h at room
temperature ; (b) washed with PBS, 1% OVA (PBSO) for 1 h ; (c)
incubated with biotinylated goat anti-rat IgG (1:500 in PBSO);
(d) washed with PBSO for 1 h ; (e) incubated with streptavidin-
Texas Red (1:500 in PBSO) ; (f) washed with PBSO for 1 h and
observed under phase contrast and fluorescence microscopy with
an Axiophot microscope (Zeiss Optical, Petersburg, VA).
Immunogold Localization ofBSA by Transmission EM.
￿
To deter-
mine ultrastructural localization ofmonomeric BSA exit pathways
in the cerebral microvasculature in experimental meningitis, im-
munogold labeling of in situ perfused monomeric BSA was per-
formed by both pre- and post-embedding methods.
Pre-embedding Immunogold Diffusion Method .
￿
After in situ per-
fusion and fixation, the brain was cut into 1-mm coronal slices,
frozen in liquid N2, and cryosectioned (10-,um thickness) with a
Frigocut (Reichert Scientific Instruments) . Sections were incubated
with the primary rat anti-BSA antibody (1:50 in PBSO)for 18 h,
washed inPBSO for 1 h, andreincubated for 18 h in goat-anti-rat
IgG coupled to 5nm gold . Afterwashingagain in PBSO for 1 h,
the tissue was subjected to the following steps : (a) fixation in 1.5%
glutaraldehyde in 0.1 M cacodylate and 5% sucrose for 1 h; (b)
post-fixation in 1% Os04 in acetate veronal buffer; (c) treatment
in2% uranyl acetate followed by gradedETOH dehydration, 50%
propylene oxide infiltration, and embedding in Epon 812 on a flat
mold . After overnight polymerization at 60°C, brain cortical spec-
imens were cut from the molds, remountedon Epondummy blocks,
and replaced in a 60°C oven for 48 h. Thin sections were then
cut, stained with uranyl acetate and lead citrate, and examined
by TEM.
Post-embedding Immunogold Labeling of Ultrathin Frozen Sections.
Washed tissue blocks were processed according to the method of
Tokuyasu (9) as modified by Milici et al . (10),which requires tissue
infiltration for2 hwith50% polyvinylpyrrolidine containing 2.3M
sucrose in 0.1Mphosphate buffer (pH 7.4), followed by mounting
on metal nails and freezing in liquid N2 . Thin frozen sections were
cut on glass knives with an ultramicrotome provided with an FC-4
cryoattachment (Reichert Scientific Instruments) . Sections were then
picked up on a drop of 1.92M sucrose containing 0.75% gelatin
in 9 mM phosphate buffer, pH 7.4, and placed on nickel grids .
Sections on grids were then floated (section side down)on the fol-
lowing solutions: (a) PBS containing 0.1% OVA three times for
10 min ; (b) rat anti-BSA diluted 1:100 in PBS/0.1% OVA, for 1 h ;
(c) PBS/0.1% OVAwashes, six times for 10 min ; (d) goat anti-rat
IgGAus, diluted 1:500 in PBS/0.1% OVA; (c) repeat washing step
as in step c; (f) fix in2% glutaraldehyde for 10 min ; (g)wash with
PBS for 10 min, and then with ddH20 for 2 min; (h) post-fix in
2% 0,04 for 20 min; (i) wash with ddH20 for 2 min ; (f) stain
with 2% uranyl acetate for 15 min ; (k) 2.5% polyvinyl alcohol
containing 0.0015% lead citrate, twice for 2.5 min . Grids were
then air dried after removing excess fluid and examined by TEM.
Morphometry .
￿
To determine the percentage of labeled plas-
malemmal vesicles, we examined 10 random low magnification
(x18,000)micrographs ofcross-sectioned pial microvessels (arteri-
olar, venular, capillary) in controlandLPS-inoculated rats perfused
with colloidal gold-BSA tracer in situ .
Results
Natural History of Experimental Meningitis
To initially characterize the natural history of the ex-
perimental subarachnoid inflammation, experiments were per-
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Kinetics ofCSF leukocytosis during experimental meningitis.
Depicited is CSF leukocyte concentration vs . time (h) after intracistemal
inoculation of rats with 25 ng E. coli 0111:B4 LPS (open squares) or saline
(closed squares) .
formed documenting the kinetics ofCSF inflammation and
functional 1251-BSA entry after intracisternal LPS inocula-
tion . As shown in Fig . 1, after intracisternal inoculation of
25 ng of E. coli 0111:B4 LPS, a significant CSF leukocyte
exudation (mean ± SE WBC = 5.82 ± 2.2 x 103) began
3-4 h later, peaked at 6 h (mean ± SE WBC = 14.1 ±
4.4 x 103), and was reversible by 24 h. Similarly, therewas
a significant functional BBB injury (as determined by CSF
penetration of systemically administered 1251-BSA) that
began 3 h post-inoculation (mean ± SE% CSF 1251-BSA =
1.42 ± 0.6), peaked at 4 h (mean ± SE% CSF 1251-BSA
= 2.7 ± 0.8), and was reversible by 24 h (see Fig . 2) . To
Hours
24
Figure 2 . Kinetics of 1251-BSA penetration into CSF during ex-
perimental meningitis . Depicited is percent 1251-BSA CSF penetration vs.
time (h) after intracisternal inoculation of rats with 25 ng E. coli 0111:B4
LPS (open squares) or saline (closed squares) .Figure 3 .
￿
Light micrograph (x63) of superficial brain cortex and meninges. Depicited is pia-arachnoid inflammation (arrows) as well as subcortical
brain edema after 4 h of experimental meningitis. A, arteriole lumen; C, brain cortex; V, venule.
confirm histologically leptomeningitis, 4 h post-intracisternal
LPS inoculation, rats were perfusion fixed in situ, specimens
from the superficial brain were collected, processed, embedded,
and sectioned (5 P,m) on an ultramicrotome, and stained with
methylene blue . As seen in Fig. 3, light microscopy (x63)
ofsuperficial brain revealedpia-arachnoid inflammation as well
as subcortical brain edema documenting gross histologic in-
jury at a time of significant functional disease.
In Situ Tracer Perfusion during Experimental Meningitis
Colloidal Gold BSA Perfusion.
￿
To localize ultrastructur-
ally the pathways ofBSA exit out of the CNS microvascula-
ture during active meningitis, rats were perfused in situ with
colloidal gold coupled to BSA 4 h after intracisternal LPS
inoculation, and the superficial brain cortical microvascula-
ture was examined by TEM. As seen in Fig . 4, there was
significant uptake ofAu-BSA into plasmalemmal vesicles (PV)
of the pial microvasculature (of infected rats) compared to
uninfected controls . To rule out nonspecific binding facili-
tated by the glutamic acid stabilizer, additional control ex-
periments were done in which infected rats were perfused
in situ with Au-BSA (stabilized with glutamic acid) or Au-
glutamic acid alone . As shown in Fig . 5, there was similar
uptake ofAu-BSA into coated vesicles as well as binding to
uncoated pits ofthe pial microvasculature, but negligible up-
take of Au-glutamic acid in a similarly infected rat . To mor-
phometrically quantitate the degree of labeling of PV, 10
random micrographs ofpial microvessels were examined from
LPS-infected and PBS control rats 4 h post-inoculation. As
seen in Table 1, there was significant and similar uptake of
Au-BSA into PV of all microvascular segments of infected,
but not control pia-arachnoid microvessels. However, no evi-
dence of transcytosis of An BSA was detected over the in-
tervals examined .
When the possibility for paracellular leak ofBSA was in-
vestigated, there was striking evidence for Au-BSA traversal
through open intercellularjunctions to the perivascular space
(see Fig. 6) . In contrast to theAu-BSA uptake into PV (which
occurred in all segments of the pial microvasculature), paracel-
lular Au-BSA exit through open intercellular junctions was




To determine the frequency of such
paracellular leaks, large fields were examined at very low
magnification in a separate series of experiments in which
rats were perfusion fixed in situ with 0.01% carbon black-
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￿
Interaction of in situ perfused colloidal Au-BSA with pial microvasculature during experimental meningitis. Note the uptake (arrows) of
Au-BSA into PV, ofa pial arteriole after 4-h experimental meningitis (A) compared with saline controls (B) . L, vessel lumen ; N, nucleus; TJ, intercellular
tight junction of pial venule. Inset shows monodispersity of colloidal Au-BSA complexes before perfusion . Bar = 0.2 AM.
3% glutaraldehyde after various durations of experimental
meningitis. Asshown in Fig. 7, compared to uninflamed con-
trols (Fig. 7 a), there was significant evidence for focal leak
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of carbon black out of large and small pial venules after 4 h
of experimental meningitis (Fig . 7, b and c) . This was also
significant compared to the negligible leak after 2-h (Fig. 7Figure 5 .
￿
Interaction of in situ perfused colloidal Au-BSA (A) vs . colloidal Au glutamic acid (B) with pial microvasculature during experimental
meningitis. Note the uptake of Au-BSA into PV of a pial venule (arrows) as well as uncoated pits (arrowheads) after 4 h of experimental meningitis
(A) . However, after similar duration (4 h) of experimental meningitis, there was no binding or uptake of Au glutamic acid (without BSA) anywhere
in the pial microvasculature. L, vessel lumen . Bar - 0 .2 pM .
d) and 24-h infection durations (Fig . 7 e), time points in which
functional CSF 1251-BSA traversal was previously document-
ed to be insignificant .
Immunolabeling of Monomeric BSA during
Experimental Meningitis
To obtain additional confirmatory evidence for BSA exit
pathways, a series of experiments were performed in which
in situ perfused monomeric BSA (40 mg/ml) was im-
munolocalized with an amity-purified rat anti-BSA antibody
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at the light andEM level. The anti-BSA antibody was raised
in rats to elicit specificity forBSA over endogenous rat serum
albumin (RSA) . After immunization, serum was harvested
and antibody was purified by proteinG affinity chromatog-
raphy with confirmation as a 180-kD band (nonreduced) by
SDS-PAGE (data not shown) . To determine the sensitivity
and specificity of the purified antibody for BSA (vs . RSA)
in the face of fixation, a series of ELISAs were performed .
As shown in Fig. 8, the primary antibody sensitivity for BSA
and specificity (vs. RSA) was achieved in the face of 4%
paraformaldehyde even when supplemented with 0.5%
Ultrastructural Localization of Albumin Fait Pathways in MeningitisTable 1 .
￿
Quantitation of in situ Perfmed Au-BSA Labeling
of PV in Pial Microvasculature
glutaraldehyde. Hence, this fixation combination was then
used for immunolocalization in situ.
Immunofiuorescent Localization.
￿
As the initial step in im-
munolocalization of BSA in situ during experimental menin-
gitis, rats were perfused with monomeric BSA 4 h afterLPS
intracisternal inoculation. After in situ fixation, brain and
heart were frozen, cryosectioned, and BSA was localized by
immunofluorescence microscopy. The heart served as a posi-
tive control and the procedure allowed the examination of
large fields including many vessels. As shown in Fig. 9, the
rat anti-BSA antibody specifically localized BSA in the heart
in all cross-sectioned microvessels (Fig. 9, a and b) as well
as the pia-arachnoid microvasculature afterLPS-induced inflam-
mation (Fig. 9, c and d); uninflamedpia-arachnoid from saline-
inoculated rats showed no detectable fluorescence. This sug-
gested that immunogold localization of BSA by transmis-
sion EM was feasible.
Immunogold Localization.
￿
To immunolocalize BSA by TEM
two complementary immunogold techniques were utilized.
Pre-embedding Immunogold Labeling.
￿
Results of the pre-
embedding immunogold diffusion technique are depicted in
Fig. 10. As shown in Fig. 10, a and b, after4 h of experimental
meningitis, there was immunodetection of enhanced BSA
binding to the luminal membrane of a pial microvessel as
well as immunolocalization within the perivascular space after
a 10-min monomeric BSA perfusion. Although a venule is
depicted in the micrograph, similar enhanced luminal mem-
brane BSA binding was observed in arterioles and capillaries
as well. When intercellular junctions were examined, there
was immunogold detection of BSA exit through open inter-
cellular junctions, corroborating that observed in Au-BSA
experiments (Fig. 10 c) . When the superficial brain microvas-
culature was examined, there was a similar enhanced luminal
membrane binding of BSA after a 10-min perfusion in rats
with experimental meningitis compared to controls (Fig. 10,
d and e). However, as opposed to the pial microvasculature,
there was no evidence of BSA in the perivascular space or
exit via intercellularjunctions. To assess if a shorter BSA per-
fusion time would yield similar results, rats were perfused




for 1 min aftera 4-h experimental meningitis. As documented
in Fig. 10f, there is less immunogold detection ofBSAbinding
to the luminal membrane as well as less (but present) im-




ding immunogold diffusion method is incapable ofdetecting
intracellular albumin tracer, such as found in other endothelia
in transcellular transport via plasmalemmal vesicles, direct
immunogold labeling of ultrathin frozen sections were done.
As shown in Fig. 11, there was immunodetectable BSA within
some PV of a pial capillary (as well as in the perivascular space)
after4 h ofexperimental meningitis. However, similar to the
Au-BSA experiments, only a minority of the PV were labeled.
Discussion
In this inquiry, we sought to identify the microvascular
subcellular pathway(s)of albumin exit across the blood brain
barrier during experimental meningitis. Using a rat model
of CSF inflammation, we investigated, at the ultrastructural
level, albumin transport by vascular perfusion of colloidal
gold-albumin complexes as well as monomeric albumin (BSA)
localized in situ by an immunogold procedure. The salient
results suggest that during meningitis, the primary site of
albumin exit is at the pia-arachnoid microvasculature,
predominates in the venular segments, and occurs primarily
via a paracellular pathway through open intercellularjunctions.
As a disease, bacterial meningitis accounts for worldwide
morbidity and mortality despite the fact that available anti-
biotics can achieve CSF bactericidal activity and are capable
of rapid bacteriologic cure. Mounting evidence in animal
models and humans suggests that induction ofinflammatory
cytokines within the CSF, before and during bacteriolysis,
initiate and perpetuate CSF neutrophil and albumin exuda-
tion across the BBB (11-13). The resultant altered CSF milieu
facilitates both vasogenic and cytotoxic brain edema and is
associated with disturbed cerebrovascular autoregulation (14);
a pathophysiology capable of precipitating neuronal injury,
seizures, and death.
In the context of previous investigation correlating ultra-
structural alterations of isolated cerebral microvessels with
functional BBB injury (8), we now report detailed ultrastruc-
tural observations on albumin exit pathways in situ at the
subcellular level in the microvascular endothelium of pia-
arachnoid and cerebral cortex. As the initial step, the kinetics
of leukocyte and 1251-BSA exudation into CSF were charac-
terized in an experimental rat model. As shown in Figs. 1-3,
intracisternal inoculation of E. coli 0111:B4-purified LPS in-
duced a reversible CSF inflammation and BBB injury that
peaked at 4-6 h, with histologic confirmation of gross lep-
tomeningitis by light microscopy.
After confirming this time point of peak functional in-
jury, initial investigations into BSA exit pathways were per-
formed by in situ tracer perfusion of colloidal gold Au-BSA
complexes. This particular tracer has been recently demon-
strated to be useful in ultrastructural definition of albumin
exit pathways in normal systemic and CNS microvasculature.







LPS inoculated Capillary 45 16 (36)
Venule 116 38 (33)
Arteriole 81 23 (28)
Control Capillary 11 0 (0)
Venule 55 1 (2)
Arteriole 73 0 (0)Figure 6 .
￿
Traversal of in situ perfused Au-BSA out an open intercellular junction (arrowheads) of a pial venule after 4 h of experimental meningitis
at low (A) and high (B) magnification . L, vessel lumen ; e, venular endothelium ; N, nucleus of marginated leukocyte . Bar = 0 .2 uM .
there appears to be specific albumin binding to endothelial
PV as well as transcytosis in systemic (6), but not CNS
microvasculature (15) . Therefore, using a similar protocol,
we could observe whether during inflammation, the CNS
microvasculature employs albumin transcytosis or uses a
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paracellular route. As shown in Fig. 4, after4 h ofeacperimental
meningitis, there was evidence for significant uptake of Au-
BSA by PV in the pial microvasculature compared to un-
inflamed controls . Although there was some limitedAu-BSA
binding to the plasmalemma proper, there was preferential
Ultrastructural Localization of Albumin Exit Pathways in Meningitis665
￿
Quagliarello et al .binding to PV and uncoated pits . Poly-L-glutamic acid was
utilized as a colloidal gold complex stabilizer given problems
faced in pilot experiments in which other stabilizers (e.g .,
polyethylene glycol) caused nonspecific binding to microvas-
cular luminal membranes . We reasoned that the anionic charge
of poly-L-glutamic acid at neutral pH would reduce the pos-
sibility of nonspecific electrostatic binding of the colloidal-
Au complexes to the endothelium . Indeed, this hypothesis
was supported by the control experiments documenting
negligible binding of Au-glutamic acid alone to inflamed pial
microvasculature (Fig. 5) . Nonetheless, even during menin-
gitis only a minority of the PV were labeled (Table 1), and
there was no evidence of selective vesicle membrane binding
or transcytosis to the abluminal surface as described by Ghitescu
et al . (6) in uninflamed systemic microvasculature, within the
time intervals tested . The increased labeling of endothelial
plasmalemmal vesicles in inflamed specimens without evi-
dence of detectable transcytosis implies that plasmalemmal
vesicles may not perform a common function (i.e., macro-
molecular transcytosis) in all endothelia .
Upon further ultrastructural examination, the only vessels
where Au-BSA was visualized in the perivascular space were
pial venules in which there was paracellular leak ofAu-BSA
through open intercellularjunctions (Figure 6) . To compen-
sate for sampling limitations inherent in electron microscopy,
this finding was corroborated on large samples of tissues per-
fused with an appropriate tracer, 0.01% carbon black (in3%
glutaraldehyde), and examined at low optical magnifications
(Fig. 7) . Perfused carbon black leaks through open intercel-
lular junctions but is limited by the vessel's basement mem-
brane, thereby labeling such injured vascular segments . As
demonstrated, there was evidence for focal leaks of carbon
black primarily out of small and large pial venules, and these
leaks showed similar reversible kinetics to the functional tzsl-
BSACSF efflux previously demonstrated (Fig. 2) . This focal
venular pattern of tracer leaks is very reminiscent of that orig-
inally described by Majno and Palade (16) in cremasteric




rat anti-BSA antibody at various dilu-
tions. Note the sensitivityand specificity
for BSA (vs . RSA) under conditions of
4% paraformaldehyde/0.5% glutaralde-
hyde fixation .
histamine and serotonin. However, the tracer leaks in the
inflamed pial microvasculature were more scattered and not
exclusively associated with post-capillary venules.
Nonetheless, in our experiments, limitations remain in the
interpretation of endothelial exit pathways of Au-BSA com-
plexes, since it is a polymeric tracer with a documented slower
rate of endothelial transcytosis than monomeric BSA (10) .
Therefore, immunolabeling studies of perfused monomeric
BSA were necessary as a corroborative investigation .
Specifically, rat anti-BSA antibody was purified, tested for
specificity under various fixation conditions by ELISA (Fig.
8), and utilized to immunolocalize monomeric BSA in situ
during experimental meningitis. After initial experiments
documented the ability of this antibody to specifically localize
BSA by immunofluorescence in situ (Fig. 9), we tested two
complementary immunogold detection methods to localize
perfused monomeric BSA during meningitis by TEM . The
pre-embedding immunogold diffusion labeling protocol (Fig.
10) allowed for immunogold labeling ofBSA with excellent
ultrastructural preservation but could not detect antigen (BSA)
at intracellular sites (i.e., PV) involved in transcytosis . The
post-embedding, direct immunogold labeling of ultrathin
frozen sections provided the opportunity to observe labeling
of vesicles (10), but at the expense of poorer ultrastructural
preservation of the inflamed microvasculature .
Results of the pre-embedding immunogold diffusion
method (Fig. 10) provided two important ultrastructural ob-
servations . First, during meningitis, there appears to be aug-
mentedmonomeric BSA binding to the luminal endothelial
membrane of microvasculature (arterioles, capillaries, and
venules) in the pia-arachnoid as well as superficial brain cortex .
Second, monomeric BSA can be immunolocalized to exit pial
venules via open intercellular junctions similar to that ob-
served with perfused Au-BSA complexes. Noteworthy is that
the paracellular leak was through an intercellular junction
in which there was no concomitant leukocyte adherence, sug-
gesting that the two phenomena are not interrelated . The
post-embedding labeling of ultrathin frozen sections corrobo-
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w mFigure 10 .
￿
Pre-embedding immunogold diffusion labeling of BSA by TEM . (A) Enhanced BSA binding to the luminal membrane of a pial venule
after 10-min BSA perfusion, 4 h post-LPS inoculation . Note the presence ofimmunodetectable BSA in the perivascular space (arrows) as well . (B) Negligible
BSA binding to the pial microvasculature in a saline control rat. (C) Immunogold detection of enhanced luminal membrane binding of BSA, as well
as exit through an open intercellular junction in a pial venule after 4 h of experimental meningitis. (D) Similiar enhanced BSA binding to the luminal
membrane ofa capillary in the superficial brain cortex after 4 h of experimental meningitis. (E) Negligible BSA binding to superficial brain microvessels
in saline-inoculated control rats. (F) Less extensive immunogold detection of BSA binding to the luminal membrane, as well as within the perivascular
space (arrowheads) with a 1-min BSA perfusion, after 4 h of experimental meningitis. L, lumen ; e, endothelial cell ; N, nucleus of endothelial cell.
Bar - 0.2 AM.
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Quagliarello et al.rated this and revealed that although there was immunodetec-
table BSA within some PV of pial capillaries during ex-
perimental meningitis, only a minority were labeled (Pig . 11),
as was noted in the Au-BSA perfusion studies .
The detection ofenhancedmonomericBSA binding to the
luminal membrane (not seen with polymeric Au-BSA com-
plexes) may relate to the higher concentration of BSA per-
fused (40 mg/ml ofmonomeric BSA vs . 80 Fig/ml of BSA
in Au-BSA perfusate) or more efficient expression of ligand
binding sites on monomeric albumin . Nonetheless, the ob-
servation is intriguing and may suggest binding of albumin
to specific albumin-binding proteins (17, 18), or other in-
ducible adhesive glycoproteins expressed on endothelium in
response to inflammatory peptides (e.g., ELAM-1, ICAM-1,
GMP-140) during meningitis (19-21) .
The finding of albumin exit via open intercellular junc-
tions of pial venules by both immunolabeling BSA and in
670 Ultrastructural
situ perfusion of Au-BSA complexes strongly supports this
paracellular route as the major exit pathway during menin-
gitis and confirms a previously unproven assumption based
on in vitro and in situ observations in systemic microvascula-
ture. Specifically, the systemic post-capillary venule has been
shown to exhibit loosely organized intercellular junctions
(compared to capillaries and arterioles) that open during vasoac-
tive amine exposure (i.e., histamine) allowing for paracellular
protein leak (16, 22) . The in situ localization of histamine
receptors in high concentration in the plamalemma overlying
the perijunctional area rich in actin and myosin further sup-
port this concept (23) . Whether histamine is a primary medi-
ator within the central nervous system, and whether its regu-
lation of endothelial contractility and paracellular leak is via
cytosolic calcium (as shown in vitro [24]) remain conjectural
but testable hypotheses. Likewise, this paracellular route of
albumin exit could result from an effect of locally produced
Localization of Albumin Exit Pathways in MeningitisFigure 11 .
￿
Direct immunogold labeling ofBSA on ultrathin frozen section (post-embedding) . Note the immunogold detection ofBSA within some
plasmalemmal vesicles (arrows) as well as within the perivascular space. L, lumen . Bar = 0 .2 AM .
inflammatory cytokines (I1rl, TNF) directly on the endo-
thelium itself. This is supported by observations in which
bothTNF and ID1 have been shown to induce both a time-
and dose-dependent increase in endothelial cell monolayer per-
meability to albumin in vitro (25) . Further studies have cor-
related endothelial monolayer permeability alterations to a
direct TNF induction of cytoskeletal changes and intercel-
lular gap formations, a pathologic response that appears to
be regulated by a pertussis toxin-sensitive G protein (26) .
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